Sartorius Aktiengesellschaft (SUVPF)

Market Cap	20.24B +27.5%
Revenue (ttm)	4.16B +4.2%
Net Income	248.13M +63.5%
EPS	n/a
Shares Out	n/a
PE Ratio	81.57
Forward PE	43.53
Dividend	0.85 (0.27%)
Ex-Dividend Date	Mar 27, 2026

Volume	1
Open	256.25
Previous Close	315.77
Day's Range	256.25 - 315.77
52-Week Range	233.92 - 333.02
Beta	1.51
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 22, 2026

About SUVPF

Sartorius Aktiengesellschaft provides bioprocess solutions, and lab products and services worldwide. The company offers analytical solutions, such as biolayer interferometry systems, high-throughput screening by cytometry systems, process analytical technology and data analytics, cell selection and retrieval, live-cell imaging and analysis systems, and surface plasmon resonance systems; cell culture solutions, including bioreactors and fermenters, cell culture reagents, supplements and matrices, nucleic acid and delivery solutions, cell culture...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1870
• Employees: 14,273
• Stock Exchange: OTCMKTS
• Ticker Symbol: SUVPF

Financial Performance

In 2025, SUVPF's revenue was 3.54 billion, an increase of 4.66% compared to the previous year's 3.38 billion. Earnings were 154.90 million, an increase of 84.40%.

Financial numbers in EUR

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Nov 9, 2026

Data Sources Report a data error